MARY SINCLAIR: Open Payments
NPI 1770063604 · JACKSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,523 in 112 payments from 10 companies in 2025. Trend: 2023 $657 · 2024 $397 · 2025 $2,523
Food & beverage: $2,412Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $651 |
| Alkermes, Inc. | 20 | $461 |
| Otsuka America Pharmaceutical, Inc. | 24 | $450 |
| Teva Pharmaceuticals USA, Inc. | 16 | $320 |
| ABBVIE INC. | 13 | $254 |
| Vanda Pharmaceuticals Inc. | 8 | $165 |
| Neurocrine BioSciences, Inc. | 4 | $99 |
| Tris Pharma Inc | 4 | $80 |
| Janssen Pharmaceuticals, Inc | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: CAPLYTA, ARISTADA, VRAYLAR, UZEDY, ABILIFY MAINTENA, ABILIFY ASIMTUFII, HETLIOZ, LYBALVI.
Industry payments across NC — which companies pay providers there.
